Veeva Systems Inc. 為北美、歐洲、亞太、中東、非洲及拉丁美洲的生命科學行業提供雲端軟件。公司總部位於加州普萊森頓。
財務指標
營業收入
2026-07-31
$927.96M
2026-04-30
$882.94M
2026-01-31
$835.95M
2025-10-31
$811.23M
營業支出
2026-07-31
$420.93M
2026-04-30
$388.91M
2026-01-31
$376.59M
2025-10-31
$370.91M
淨利潤
2026-07-31
$273.42M
2026-04-30
$260.93M
2026-01-31
$244.2M
2025-10-31
$236.2M
淨利潤率
2026-07-31
29.46%
2026-04-30
29.55%
2026-01-31
29.21%
2025-10-31
29.11%
每股收益
2026-07-31
$1.68
2026-04-30
$2.24
2026-01-31
$2.06
2025-10-31
$2.04
息稅折舊攤銷前利潤
2026-07-31
$360.4M
2026-04-30
$284.69M
2026-01-31
$328.94M
2025-10-31
$322.49M
有效稅率
2026-07-31
21.77%
2026-04-30
24.91%
2026-01-31
23.09%
2025-10-31
24.48%
項目
2026-07-31
2026-04-30
2026-01-31
2025-10-31
營業收入
$927.96M
$882.94M
$835.95M
$811.23M
營業支出
$420.93M
$388.91M
$376.59M
$370.91M
淨利潤
$273.42M
$260.93M
$244.2M
$236.2M
淨利潤率
29.46%
29.55%
29.21%
29.11%
每股收益
$1.68
$2.24
$2.06
$2.04
息稅折舊攤銷前利潤
$360.4M
$284.69M
$328.94M
$322.49M
有效稅率
21.77%
24.91%
23.09%
24.48%
常見問題
VEEV represents Veeva Systems, a cloud software provider focused on the global life sciences industry. Its products support clinical trials, regulatory submissions, quality management, and commercial operations for pharmaceutical and biotechnology companies. Veeva also offers CRM tools tailored to life sciences and expanding solutions in areas such as medical devices and consumer goods. The company generates revenue primarily through subscription services, which gives it a recurring revenue model that many investors monitor.
Recent performance for VEEV depends on current market conditions and company-specific news, so the exact price change is best confirmed using the latest quote and chart on this page. Investors can review the displayed daily, weekly, and year-to-date moves to see how the stock has trended. Performance may also be compared with relevant software or healthcare technology benchmarks to provide context.
Evaluating VEEV's valuation typically involves comparing its price to measures such as earnings, sales, and cash flow, along with growth expectations. Because software companies often reinvest heavily, metrics like price-to-sales or enterprise value-to-revenue can be useful alongside the P/E ratio. It is also helpful to compare VEEV against similar cloud or healthcare technology companies and to consider whether the current valuation reflects its growth and profitability outlook.
Trading outside regular U.S. market hours may be possible through certain brokers that offer pre-market and after-hours sessions. These sessions can have lower liquidity, wider spreads, and higher volatility than the standard trading day. Whether VEEV is available for extended-hours trading depends on the specific brokerage and venue, so investors should check with their platform for availability and any associated risks.
VEEV is a listed U.S. stock and generally sees meaningful daily trading volume, though activity can vary with market conditions and news. Higher liquidity usually means tighter bid-ask spreads and easier execution for typical orders, while volume spikes may occur around earnings or major announcements. The latest volume and average volume figures on this page can provide a clearer, up-to-date picture of trading activity.
Veeva Systems has historically not paid a regular cash dividend, instead retaining earnings to fund growth and reinvestment in its business. Dividend policies can change over time, so investors should verify the latest status through VEEV's official investor relations materials or the dividend information displayed on this page. For income-focused investors, that distinction matters when comparing VEEV with dividend-paying software or healthcare companies.